GGHC
NVLN

Gilder Gagnon Howe & Co’s Novelion Therapeutics Inc. Common Shares NVLN Stock Holding History

Gilder Gagnon Howe & Co’s Portfolio NVLN Stock Details NVLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-21,833
Closed -$202K – 307
2017
Q2 		$202K Sell
21,833
-309,766
-93% -$2.87M ﹤0.01% 247
2017
Q1 		$3.56M Buy
331,599
+71,409
+27% +$767K 0.06% 155
2016
Q4 		$2.19M Buy
+260,190
New +$2.19M 0.04% 158